EDC
Eildon Capital Limited (EDC)
Market Closed
ASX ASX Primary - Market Cap
- P/E Ratio
201.3% Div Yield
0 Volume
- Eps
Earnings results expected in 65 days
Summary
EDC closed yesterday lower, a decrease of 2.38% from Thursday's close, completing a monthly increase of 2.5%. Over the past 12 months, EDC stock lost -11.35%.
EDC pays dividends to its shareholders, with the most recent payment made on Jan 22, 2025. The next estimated payment will be in 4 months ago on Jan 22, 2025 for a total of A$0.06183.
The last earnings report, released on Feb 24, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Aug 25, 2025.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on ASX (AUD).
Want to track EDC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Eildon Capital Limited Dividends
| EDC EDC In 2 days Estimated | Final | A$0.06 Per Share |
| EDC EDC 5 months ago Paid | Final | A$0.06 Per Share |
| EDC EDC 11 months ago Paid | Interim | A$0.06 Per Share |
| EDC EDC 27 Dec 2023 Paid | Final | A$0.05 Per Share |
| EDC EDC 23 Jun 2023 Paid | Interim | A$0.02 Per Share |
| EDC EDC 30 Mar 2023 Paid | Other | A$0.01 Per Share |
Eildon Capital Limited Earnings
| 25 Aug 2025 (65 Days) Date | | - Cons. EPS | - EPS |
| 24 Feb 2025 Date | | - Cons. EPS | - EPS |
| 20 Nov 2024 Date | | - Cons. EPS | - EPS |
| 26 Aug 2024 Date | | - Cons. EPS | - EPS |
| 23 Aug 2024 Date | | - Cons. EPS | - EPS |
| EDC EDC In 2 days Estimated | Final | A$0.06 Per Share |
| EDC EDC 5 months ago Paid | Final | A$0.06 Per Share |
| EDC EDC 11 months ago Paid | Interim | A$0.06 Per Share |
| EDC EDC 27 Dec 2023 Paid | Final | A$0.05 Per Share |
| EDC EDC 23 Jun 2023 Paid | Interim | A$0.02 Per Share |
| EDC EDC 30 Mar 2023 Paid | Other | A$0.01 Per Share |
| 25 Aug 2025 (65 Days) Date | | - Cons. EPS | - EPS |
| 24 Feb 2025 Date | | - Cons. EPS | - EPS |
| 20 Nov 2024 Date | | - Cons. EPS | - EPS |
| 26 Aug 2024 Date | | - Cons. EPS | - EPS |
| 23 Aug 2024 Date | | - Cons. EPS | - EPS |
Eildon Capital Limited (EDC) FAQ
On which exchange is it traded?
Eildon Capital Limited is listed on ASX.
What is its stock symbol?
The ticker symbol is EDC.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
What is the earnings per share?
The EPS is 0.
When is the next earnings date?
The next earnings report will release on Aug 25, 2025.
Has Eildon Capital Limited ever had a stock split?
No, there has never been a stock split.
Eildon Capital Limited Profile
| Biotechnology Industry | Healthcare Sector | Mr. Richard Hague CEO | ASX Exchange | AU000000EDC5 ISIN |
| United States Country | 42 Employees | 24 Dec 2024 Last Dividend | - Last Split | - IPO Date |
RegenETP, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. The company was formerly known as PolarityTE, Inc. and changed its name to RegenETP, Inc. in August 2023. RegenETP, Inc. is headquartered in Salt Lake City, Utah.
Contact Information
Address: 1960 South 4250 West
Phone: 800 560 3983
Website: https://www.polarityte.com
2025 © Marketlog. All Rights Reserved.
